Genezen Acquires uniQure’s Gene Therapy Operations
Key Highlights Genezen acquires uniQure’s Lexington gene therapy operations. New strategic supply agreements for uniQure’s clinical portfolio and CSL’s HEMGENIX®.…
Browsing Tag
Ampersand Capital Partners
1 post